Achilles Therapeutics (ACHL)
(Delayed Data from NSDQ)
$0.71 USD
0.00 (0.28%)
Updated Sep 18, 2024 03:58 PM ET
After-Market: $0.71 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.41 | 0.00% |
Earnings Summary
For their last quarter, Achilles Therapeutics (ACHL) reported earnings of -$0.41 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for ACHL's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.41 per share, reflecting a year-over-year increase of 2.38%.
Earnings History
Price & Consensus
Zacks News for ACHL
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
ACHL: What are Zacks experts saying now?
Zacks Private Portfolio Services